Kristie Greear, PA
Medical · Dearborn, MINPI 1710492590
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 578 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,259 and has fallen 78.4% since, to $704 in 2025. Among medical clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 578 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Alnylam Pharmaceuticals Inc.$1K
- Johnson & Johnson$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$973
- Pfizer$752
- Merck$708
- plus $4K from 21 others
What the payments were for
- Food & beverage$9,713100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 85 | $1,260 |
| Alnylam Pharmaceuticals Inc. | 73 | $1,141 |
| Johnson & Johnson | 73 | $1,018 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 34 | $973 |
| Pfizer | 55 | $752 |
| Merck | 40 | $708 |
| Lexicon Pharmaceuticals, Inc. | 34 | $668 |
| AstraZeneca | 35 | $568 |
| Boehringer Ingelheim | 29 | $511 |
| Sanofi-aventis U.S. LLC | 16 | $311 |
| Amgen | 16 | $292 |
| Amarin Pharma, Inc. | 16 | $254 |
| Esperion Therapeutics, Inc. | 18 | $243 |
| Novo Nordisk | 10 | $213 |
| Heartflow, Inc. | 14 | $179 |
| Bayer | 5 | $123 |
| Actelion Pharmaceuticals US, Inc. | 4 | $103 |
| Lilly USA, LLC | 5 | $81 |
| Philips North America LLC | 3 | $69 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Boston Scientific | 2 | $36 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $33 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Edwards Lifesciences | 2 | $19 |
| United Therapeutics Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,726 in reported general payments places this provider in the 90th percentile of 755 medical providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in Dearborn
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$56K
- David WilkinsMuskegon$41K
- Mark RosenBerkley$32K
- Robert DemeesterRoyal Oak$27K
- John BrabantDetroit$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.